Patients commonly experience gastrointestinal side effects including nausea, vomiting, diarrhea, and constipation, which may further compromise nutritional status
Nevertheless, in a network meta-analysis comparing short-acting and long-acting GLP-1RAs when used in conjunction with basal insulin, long-acting GLP-1RAs resulted in significantly greater reductions in glycated hemoglobin (HbA1c), fasting plasma glucose, and body weight compared to short-acting GLP-1RAs, with better gastrointestinal tolerability [15]
Research shows that absorption rates are similar across approved sites (abdomen, thigh, upper arm), but the injection site can affect comfort and consistency
Legislators are pushing for workplace accommodations for those navigating peri/menopause
This is different from insulin injections, which work no matter what